BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 24988689)

  • 1. Metabolic syndrome and diabetes mellitus in childhood cancer survivors.
    Bizzarri C; Bottaro G; Pinto RM; Cappa M
    Pediatr Endocrinol Rev; 2014 Jun; 11(4):365-73. PubMed ID: 24988689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prevalence of the metabolic syndrome and type 2 diabetes mellitus in children and adolescents.
    Molnár D
    Int J Obes Relat Metab Disord; 2004 Nov; 28 Suppl 3():S70-4. PubMed ID: 15543223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology of paediatric metabolic syndrome and type 2 diabetes mellitus.
    De Ferranti SD; Osganian SK
    Diab Vasc Dis Res; 2007 Dec; 4(4):285-96. PubMed ID: 18158698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies.
    O'Neill S; O'Driscoll L
    Obes Rev; 2015 Jan; 16(1):1-12. PubMed ID: 25407540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity and metabolic changes are common in young childhood brain tumor survivors.
    Pietilä S; Mäkipernaa A; Sievänen H; Koivisto AM; Wigren T; Lenko HL
    Pediatr Blood Cancer; 2009 Jul; 52(7):853-9. PubMed ID: 19165891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Childhood obesity and its health consequence in China.
    Li Y; Yang X; Zhai F; Piao J; Zhao W; Zhang J; Ma G
    Obes Rev; 2008 Mar; 9 Suppl 1():82-6. PubMed ID: 18307705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of metabolic syndrome in obese Turkish children and adolescents.
    Atabek ME; Pirgon O; Kurtoglu S
    Diabetes Res Clin Pract; 2006 Jun; 72(3):315-21. PubMed ID: 16325296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic syndrome in obese Thai children and adolescents.
    Iamopas O; Chongviriyaphan N; Suthutvoravut U
    J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S126-32. PubMed ID: 22043765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The metabolic syndrome in South Asians: epidemiology, determinants, and prevention.
    Misra A; Khurana L
    Metab Syndr Relat Disord; 2009 Dec; 7(6):497-514. PubMed ID: 19900153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. All in the family: Clueing into the link between metabolic syndrome and hematologic malignancies.
    Karmali R; Dalovisio A; Borgia JA; Venugopal P; Kim BW; Grant-Szymanski K; Hari P; Lazarus H
    Blood Rev; 2015 Mar; 29(2):71-80. PubMed ID: 25433571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E; Minuto F; Colao A; Ferone D
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Very severely obese patients have a high prevalence of type 2 diabetes mellitus and cardiovascular disease.
    Vinciguerra F; Baratta R; Farina MG; Tita P; Padova G; Vigneri R; Frittitta L
    Acta Diabetol; 2013 Jun; 50(3):443-9. PubMed ID: 23447004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency of metabolic syndrome in type 2 diabetes and its relationship with insulin resistance.
    Ahmed S; Ahmed SA; Ali N
    J Ayub Med Coll Abbottabad; 2010; 22(1):22-7. PubMed ID: 21409896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between serum testosterone levels and features of the metabolic syndrome defining criteria in patients with type 2 diabetes mellitus.
    Ogbera AO
    West Afr J Med; 2011; 30(4):277-81. PubMed ID: 22669833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term risk of diabetes, hypertension and left ventricular hypertrophy associated with the metabolic syndrome in a general population.
    Mancia G; Bombelli M; Facchetti R; Madotto F; Corrao G; Trevano FQ; Giannattasio C; Grassi G; Sega R
    J Hypertens; 2008 Aug; 26(8):1602-11. PubMed ID: 18622239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment factors rather than genetic variation determine metabolic syndrome in childhood cancer survivors.
    van Waas M; Neggers SJ; Uitterlinden AG; Blijdorp K; van der Geest IM; Pieters R; van den Heuvel-Eibrink MM
    Eur J Cancer; 2013 Feb; 49(3):668-75. PubMed ID: 23036851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The epidemiology and molecular mechanisms linking obesity, diabetes, and cancer.
    Ferguson RD; Gallagher EJ; Scheinman EJ; Damouni R; LeRoith D
    Vitam Horm; 2013; 93():51-98. PubMed ID: 23810003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic syndrome in pediatrics: old concepts revised, new concepts discussed.
    D'Adamo E; Santoro N; Caprio S
    Endocrinol Metab Clin North Am; 2009 Sep; 38(3):549-63. PubMed ID: 19717004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocrine complications and components of the metabolic syndrome in survivors of childhood malignant non-brain solid tumors.
    Shalitin S; Laur E; Lebenthal Y; Ash S; Yaniv I; Phillip M
    Horm Res Paediatr; 2014; 81(1):32-42. PubMed ID: 24246763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediabetes and type 2 diabetes in youth: an emerging epidemic disease?
    Cali AM; Caprio S
    Curr Opin Endocrinol Diabetes Obes; 2008 Apr; 15(2):123-7. PubMed ID: 18316946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.